Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8001 to 8050 of 8140 results

  1. NICE to produce rapid guideline to diagnose and treat rare blood clotting condition associated with COVID-19 vaccination

    NHS England has asked NICE to develop a guideline on the management and follow up of blood clots and low platelet counts associated with COVID-19 vaccination.

  2. NICE to retire Guidance app

    Following improved access and optimisation of the website, the NICE guidance app will no longer be available for download with plans to phase it out by January 2019.

  3. NICE to support the NHS in gaining free trial access to medical research

    NICE is participating in a pilot trial which aims to support the NHS in gaining free access to the latest high-quality clinical and scientific research.

  4. NICE unveils safe staffing plans for nursing care in wards

    NICE has published new guidance setting out ‘red flag events’ which warn when nurses in charge of shifts must act immediately to ensure they have enough staff to meet the needs of patients on that ward.

  5. NICE updates guideline on alcohol education in schools

    NICE is updating its guideline on Alcohol interventions in secondary and further education.

  6. NICE updates managing COVID guideline with new monoclonal antibody recommendations

    NICE has updated its managing COVID-19 guideline to include new recommendations on using monoclonal antibodies to treat COVID-19 patients in hospital.

  7. NICE updates rapid COVID-19 guideline on critical care

    We have listened to concerns raised by patient groups about the application of our rapid COVID-19 critical care guideline.

  8. NICE updates recommendations for two COVID-19 therapeutics

    NICE has updated its advice on two therapeutics for managing COVID-19 – remdesivir and colchicine.

  9. NICE urges further research on the safety and efficacy of two procedures to treat conditions affecting women

    The long-term safety and efficacy is inadequate on two procedures NICE is calling for further evidence on

  10. NICE urges professionals to correctly gather information on people's alcohol drinking habits to ensure those who need help are not missed

    Thousands of people asked each year could be missing out on brief interventions to help curb problem drinking, or a potential referral to specialist alcohol services.

  11. NICE welcomes appointment of six new Board members

    NICE is delighted with today’s (15 March) announcement from the Department of Health & Social Care appointing six new non-executive directors to its Board following their approval by the Secretary of State.

  12. NICE welcomes new intake of Fellows and Scholars

    Improving the uptake of hepatitis B vaccination among at risk groups, developing tools to make evidence-based medicine more accessible, and carrying out a clinical outcome assessment in hand surgery are just some of the projects planned by the latest group of fellows and scholars.

  13. NICE welcomes new senior executive team appointments

    New Chief Medical Officer, Chief People Officer and Director of Implementation and Partnerships appointed by NICE

  14. Nine treatment options to be made available for adults with depression or an anxiety disorder

    Six digitally enabled therapies for adults with anxiety disorders and three for adults with depression have been recommended for use in the NHS while further data is gathered, NICE has said.

  15. Skin cancer drug recommended for routine NHS use

    An appeal period has now opened until 26 February 2021.

  16. Non-invasive MRI scan for Prostate Cancer recommended by NICE

    NICE has recommended the scan as a first-line investigation for people with suspected clinically localised prostate cancer.

  17. Novel oral anticoagulants an option for patients with atrial fibrillation

    Offering patients anticoagulants could help prevent thousands of strokes and premature deaths from atrial fibrillation (AF), according to NICE.

  18. Offer cardiac rehabilitation 'as soon as possible' to heart attack patients

    Cardiac rehabilitation should be offered as soon as possible to people who have had an myocardial infarction (MI) to help them get back to everyday life as quickly as possible, says NICE.

  19. Offer less invasive treatments before surgery for varicose veins

    Surgery should only be offered to treat varicose veins if other less invasive treatments are unsuitable for patients, according to latest guidance from NICE.

  20. Offer weight loss surgery to obese people with diabetes

    The NHS should offer weight loss surgery to thousands more people in order to tackle an epidemic of type 2 diabetes, says NICE.

  21. Use antibiotics effectively to reduce drug-resistance

    Good management of antibiotics can halve the number of people picking-up drug-resistant infections in hospital, new data suggests.

  22. Use NICE quality standards to guide good quality social care, says CQC

    Social care services should use NICE guidance and quality standards to help identify and define good quality care, according to the Care Quality Commission (CQC).

  23. Use paracetamol to relieve a sore throat rather than antibiotics

    The majority of sore throats do not need antibiotics and medicated lozenges may only help to reduce pain by a small amount, NICE says.

  24. In the bag - making moving between hospital and social care better

    The introduction of a 'red bag' Hospital Transfer Pathway has helped to improve and speed up the transfer between hospital and care home settings.

  25. Mental health funding of £1.8m welcomed by NICE and MHRA to explore regulation of digital mental health tools

    NICE and the MHRA have been awarded £1.8m funding by Wellcome over three years to explore and produce guidance on regulating digital mental health tools.

  26. Wireless device recommended for treating people with overactive bladder

    Axonics SNS has potential to save the NHS around £6,200 per patient if the device lasts more than six years

  27. Women with moderate to severe fibroids set to be offered new one-a-day treatment following final draft guidance from NICE

    Around 4,500 women with uterine fibroids will be eligible for a new oral treatment after NICE recommended relugolix with estradiol and norethisterone acetate (also called Ryeqo and made by Gedeon Ritcher UK) in final draft guidance.

  28. A new approach to prioritising requests for NICE Scientific Advice

    Dr Jacoline Bouvy explains the new NICE Scientific Advice prioritisation process.

  29. A new instrument for consideration of a broader range of benefits for people, their families and carers

    For the last three years, NICE has been part of a research project investigating how quality of life measures used to evaluate healthcare treatments such as drugs can be extended into areas of social care and public health

  30. A 'safe space' for addressing complex health technology assessment challenges

    Nick Crabb discusses how we’re developing a collaborative space for research and development, to help us create new methods and processes for health technology assessment.

  31. People growing older with learning disabilities should get regular health checks, says NICE

    NICE says people growing older with learning disabilities need to have annual health checks to help them manage conditions that can quickly affect them as they grow older.

  32. People with advanced or metastatic urothelial cancer to get life-extending treatment

    Around 130 people per year with untreated locally advanced or metastatic urothelial cancer will be eligible for a new life-extending treatment after NICE published final draft guidance today (30 September 2021) recommending atezolizumab.

  33. Place young people moving into adult services at the heart of decisions about care

    Young people who are moving from children’s to adults’ services should be placed at the heart of decisions about their care, NICE says.

  34. Poor discharge practice leading to 'unnecessary patient suffering'

    Poor hospital discharge practice is leading to unnecessary patient suffering and millions in wasted resources, according to a new report.

  35. Positive healthcare experience for babies, children and young people essential to their wellbeing

    New guideline from NICE recommends ensuring children and young people are fully informed about their health so that they are empowered to take an active role in their healthcare.

  36. Pregnant women to be offered first test to help diagnose pre-eclampsia

    Midwives caring for pregnant women can use one of four blood tests to help diagnose suspected preterm pre-eclampsia, NICE has said in new draft diagnostic guidance.

  37. Price discount helps give green light for breast cancer drug pertuzumab

    NICE approves the third breast cancer drug is as many weeks as pertuzumab is recommended to shrink tumours in some people with breast cancer so surgery can take place.

  38. Procedure carried out on unborn babies with spina bifida could improve their neurodevelopment

    Operations are set to start taking place in the NHS

  39. Professor Gillian Leng to retire from NICE

    Professor Leng has spent more than 20 years working at NICE

  40. Prompt diagnosis of social anxiety disorder leads to effective treatment

    A prompt diagnosis of social anxiety disorder is crucial in ensuring people access the most clinical and cost effective treatment, according to NICE.

  41. Recruitment begins to fill up to seven non-executive roles on the NICE board

    Roles will contribute to the development of NICE’s strategic objectives

  42. Register now for the HTAi 2021 Virtual Annual Meeting

    The Health Technology Assessment International (HTAi) 2021 Annual Meeting will be held virtually from 19-23 June 2021, and registration is now open.

  43. Rehabilitation after traumatic injury should support people in resuming their lives

    NICE has today (27 July 2021) published a new draft guideline covering rehabilitation after traumatic injury.

  44. Remove earwax if a build-up is causing hearing loss problems, NICE tells primary care

    GP surgeries or community clinics should offer to remove earwax if a build-up is contributing to someone’s hearing loss.

  45. Speeding up the adoption of health technologies

    NICE launches The Office for Market Access to work with industry to speed up the adoption of new medicines, devices and diagnostics by the NHS.

  46. Once-a-day capsule for people with some forms of ovarian, fallopian tube and peritoneal cancer recommended for routine use in the NHS

    The 20th cancer treatment to go through the Cancer Drugs Fund following a period of managed access has been recommended for routine use in the NHS by NICE in final draft guidance published today (24 February).

  47. Ovarian cancer patients to have NICE-approved drug combination option on Cancer Drugs Fund

    A potentially life-extending drug combination for some people with advanced, high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer will now be available on the Cancer Drugs Fund (CDF), following its approval by NICE in draft guidance published today.

  48. Over 500 people a year can access a new life extending lung cancer treatment after NICE recommends its use within the Cancer Drugs Fund

    An innovative life-extending drug for treating mutation-positive locally advanced or metastatic non-small-cell lung cancer (NSCLC) in adults is being recommended by NICE as an option for use within the Cancer Drugs Fund.

  49. Over 600 people set to benefit from innovative lung cancer treatment within the Cancer Drugs Fund

    More than 600 people could benefit from an innovative drug for a form of lung cancer as NICE publishes final draft guidance recommending osimertinib within the Cancer Drugs Fund.

  50. Over 700 people a year could benefit from a new potentially life-extending lung cancer drug which targets a specific genetic mutation

    New potentially life-extending lung cancer drug which targets a specific genetic mutation recommended by NICE